Learn, Analyse & Invest
only with
only with
+91
Download Orca
Indrayani Biotech Ltd.
Indrayani Biotech
₹ 0.00
0.00 (0.00)%
NSE
BSE
Miscellaneous
Small-cap - With a market cap of ₹91.33 Cr.
| EX-Date | Purpose |
|---|---|
| 22 06 2021 | Audited Results |
| 30 06 2021 | Audited Results |
| 05 07 2021 | Quarterly Results |
| 16 07 2021 | Quarterly Results |
| 18 08 2021 | A.G.M. |
| 03 09 2021 | A.G.M. |
| 14 11 2021 | Quarterly Results & Inter alia, to consider and approve : 2. The resignation of Mrs. Roopa Ravikumar, Company Secretary & Compliance officer. 3. The appointment of Ms. Charu Latha as the Company Secretary & Compliance Officer. 4. The appointment of KRA ASSOCIATES as secretarial auditor of the Company. 5. Filing of an application before the Hon?ble NCLT, Chennai for reopening of books of accounts of the Company. |
| 14 02 2022 | Quarterly Results & Inter alia to approve - The Appointment of Secretarial Auditor for the Company for the FY 2021-22. |
| 21 03 2022 | Inter alia, to consider and adopt the following agenda: * |1. To consider and approve the increase of authorized share capital of the company with the approval of the shareholders in the coming EGM. 2. To consider and approve to raise upto Rs. 28,00,00,000 (Rupees Twenty Eight Crores only) through Preferential allotment of Compulsorily Convertible Preference Shares and Share Warrants with the approval of the shareholders in the coming EGM. 3. To fix the date, venue, and mode of conducting the Extra Ordinary General Meeting of the Company. 4. To consider and approve draft notice of the general meeting along with the explanatory statement for the purpose of passing the special resolution. 5. To consider and approve the appointment of scrutinizer for e-voting of resolutions passed at EGM. 6. Any other business with the permission of the chair. |
| 28 03 2022 | Preferential Issue of shares (Revised) |
| 06 05 2022 | Inter alia to consider and approve the formation of ?Allotment Committee? pursuant to the powers of Board given under Section 179 of the Companies Act, 2013 and in reference to the resolution passed by the Board of Directors of the company on 16 July 2021. The Allotment Committee shall be responsible for the allotment of Compulsorily Convertible Preference Shares (CCPSs) and Warrants approved by the Board of Directors vide Board Meeting dated March 28, 2022 and by the Shareholders of the Company vide Extra-Ordinary General Meeting dated April 25, 2022. The allotment committee will meet thrice and shall allot the securities in three tranches on the following dates: 1. May 06, 2022 (Friday) 2. May 09, 2022 (Monday) 3. May 12, 2022 (Thursday) |
| 30 05 2022 | Audited Results |
| 13 08 2022 | Quarterly Results |
| 05 09 2022 | A.G.M. |
| 14 11 2022 | Quarterly Results |
| 14 02 2023 | Quarterly Results |
| 30 05 2023 | Audited Results |
| 14 06 2023 | Audited Results |
| 11 08 2023 | Quarterly Results |
| 01 11 2023 | Dividend on Preference Shares & Inter alia, to consider and approve:- 1. To recommend Payment of dividend on 12% Compulsorily Convertible Preference Shares. 2. To consider and approve the allotment of Equity shares by conversion of Compulsorily Convertible Preference Shares subject to lock in period of 6 months. 3. To consider and approve the conversion of Warrants into Equity Shares subject to lock in period of 6 months. 4. Any other matter with the permission of the chair. |
| 14 11 2023 | Quarterly Results |
| 10 01 2024 | Increase in Authorised Capital & Inter alia, to transact the following business: 1. To consider the proposal for increasing the authorized share capital subject to the shareholders? approval. 2. To consider and approve the conversion of unsecured loans into equity under Section 62(3) of the Companies Act, 2013 subject to the shareholders? approval. 3. Any other business with the permission of the Chair. |
| 10 02 2024 | Quarterly Results |
| 14 11 2024 | Quarterly Results & Right Issue of Equity Shares |
| 14 02 2025 | Quarterly Results |
| 27 02 2025 | Quarterly Results |
| 03 04 2025 | Right Issue of Equity Shares |
| 09 06 2025 | Audited Results(Cancelled) (Cancelled) |
| 12 06 2025 | Audited Results |
| 14 08 2025 | Quarterly Results |
| 30 08 2025 | Inter alia, to consider and approve:- 1.Notice of the 33rd Annual General Meeting of the company. 2.Disinvestment from Material Subsidiary - Dindigul Farm Product Limited. 3.Reclassification from Promoter status to Public shareholder status at Dindigul Farm Product Limited. 4.Rescindment Of Resolution Passed at the 32nd Annual General Meeting for Increasing the Authorized Share Capital. 5.Increase of Authorised share capital of the Company from Rs.65 crores to Rs.85 crores comprising 8.50 crores equity shares of Rs. 10/- each (Eight Crores and Fifty Lakhs) and consequential amendment of the capital clause in the Memorandum of Association of the Company. 6.Appointment of Mr. Swaminathan (DIN: 02481041) as Whole-Time Director. 7.Appointment of Mr. Singarababu Indirakumar (DIN: 00892351) as Whole-Time Director. |
| 14 11 2025 | Quarterly Results |
| 11 12 2025 | Quarterly Results |
| 26 02 2026 | Quarterly Results |
| 09 04 2026 | Scheme of Arrangement |
News
